CXCL12 and neoplasm: The chemokine CXCL12 released from tumor cells and CAFs may suppress the infiltration of T lymphocytes through a mechanism called chemorepulsion mediated by CXCR4, which is the receptor for CXCL12 and also expressed on T lymphocytes [27, 44, 45].